Ono Pharmaceutical Income from Continuous Operations 2010-2024 | OPHLF
Ono Pharmaceutical income from continuous operations for the twelve months ending December 31, 2024 was $0.619B, a 12.75% decline year-over-year.
- Ono Pharmaceutical annual income from continuous operations for 2025 was $0.331B, a 62.52% decline from 2024.
- Ono Pharmaceutical annual income from continuous operations for 2024 was $0.883B, a 5.74% increase from 2023.
- Ono Pharmaceutical annual income from continuous operations for 2023 was $0.836B, a 16.36% increase from 2022.